0.59 | 1.27%
| Price and Volume | |
|---|---|
| Recent Price | 46.55 |
| 52 Week High | 62.64 |
| 52 Week Low | 42.02 |
| Avg. Daily Vol. (Mil) | 0.66 |
| Beta (3 year) | 0.98 |
| Share Related Items | |
| Mkt Cap (Mil) | 2,581.43 |
| Shares Out (Mil) | 55.46 |
| Float (Mil) | 50.48 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.00 |
| Current Ratio | 1.40 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.27 |
| Valuation Ratios | |
| Price Earnings | 21.00 |
| Price/Sales | 1.13 |
| Price/Book | 2.08 |
| Price/Cash Flow | 10.70 |
| Per Share Data | |
| Earnings | 2.22 |
| Sales | 41.17 |
| Book Value | 22.34 |
| Cash Flow | 4.36 |
| Business Summary | |
|---|---|
| Covance In. is a drug development services company, which provides a range of early-stage and late-stage product development services on a worldwide basis mainly to the pharmaceutical, biotechnology and medical device industries. | |
| General Information | |
| 210 Carnegie Center
Princeton, NJ 08540 |
|
| www.covance.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 10497 | |
| CEO: Joseph L. Herring | |
| Short Interest | |
| Current Month (Mil) | 3.47 |
| Previous Month (Mil) | 4.18 |
| Short Interest Ratio (Days) | 5.00 |
| Management Effectiveness | |
| Return on Equity | 10.90 |
| Return on Assets | 6.10 |
| Return on Investments | 10.90 |
| Profitability | |
| Gross Margin | 34.70 |
| EBIT Margin | 7.60 |
| Profit Margin | 5.90 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,522.83 | 1,324.08 | 2,850.32 | 17.12 |
Oil *
106.43
|
|
UP
68.00 |
UP
6.26 |
UP
12.79 |
DOWN
0.33 |
10 Yr
1.71%
SPDR Gold
151.02
|
|
+0.55%
|
+0.48%
|
+0.45%
|
-1.89%
|
Data delayed 20 minutes |
Connect with TheStreet